Biomarkers: Which Ones Are Worthwhile? (Personalised Risk)
by Prateek Chopra | June 11, 2026 | Diabetes Conferences | ADA 2026 | 0 comments Background: Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality in individuals with type 2 diabetes (T2D), despite advances in risk factor management. Accurate risk stratification is essential to identify high-risk individuals and guide personalized preventive strategies. […]
Biomarkers: Which Ones Are Worthwhile? (Personalised Risk) Read Post »